[1]
V. Bypaneni, J. Kamma, and M. Palanivelu, “Risk Assessment and Analytical Control of Nitrosamine and NDSRI Impurities in Pharmaceutical Dosage Forms”, ijpbs, vol. 17, no. 2, pp. 1–9, Jun. 2026.